Invention Grant
- Patent Title: Butylphthalide-telmisartan hybrids, preparation method and application thereof
-
Application No.: US16478400Application Date: 2018-01-04
-
Publication No.: US11028073B2Publication Date: 2021-06-08
- Inventor: Zhangjian Huang , Tao Pang , Cunfang Wang , Wenbin Zeng , Jinxiang Deng , Weijie Wu , Tingyu Huang
- Applicant: GUANGDONG LONGFU MEDICINE CO., LTD.
- Applicant Address: CN Zhongshan
- Assignee: GUANGDONG LONGFU MEDICINE CO., LTD.
- Current Assignee: GUANGDONG LONGFU MEDICINE CO., LTD.
- Current Assignee Address: CN Zhongshan
- Agency: Kagan Binder, PLLC
- Priority: CN201710033418.6 20170118
- International Application: PCT/CN2018/071308 WO 20180104
- International Announcement: WO2018/133670 WO 20180726
- Main IPC: C07D235/18
- IPC: C07D235/18 ; C07D257/04 ; C07D403/10 ; C07D403/04 ; A61P9/10 ; A61P25/16 ; A61P29/00

Abstract:
The invention discloses a butylphthalide-telmisartan heterocomplex, a preparation method and an application thereof. The invention specifically relates to an optically active ring-opening butylphthalide-telmisartan heterocomplex shown in formula I or a pharmaceutically acceptable salt or ester thereof, a preparation method thereof, a pharmaceutical composition containing the compounds, and a pharmaceutical application thereof, particularly application in prevention and treatment of neuroinflammation-related diseases, including ischemic stroke, Alzheimer's disease, brain trauma, Parkinson's disease, multiple sclerosis, depression and so on.
Information query